The Food and Drug Administration has approved another generic version of the abortion drug mifepristone, drawing outrage from anti-abortion groups and lawmakers.
Why it matters: The decision adds to conservative scrutiny of the agency and Commissioner Marty Makary amid a push to impose new limits on dispensing the abortion pill.